{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T21:50:53Z","timestamp":1791669053609,"version":"4.3.4"},"reference-count":139,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:00:00Z","timestamp":1791590400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:00:00Z","timestamp":1791590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"DOI":"10.1007\/s00210-026-05970-x","type":"journal-article","created":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T21:32:12Z","timestamp":1791667932000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacological features of mesoionic compounds: antitumoral effects and bioenergetic disruption of sydnones and 1,3,4-thiadiazolium derivatives"],"prefix":"10.1007","author":[{"given":"Andr\u00e9 Felipe","family":"Naidek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariane Londero","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Carolina","family":"Stipp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"de Jesus da Silva Claudino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurea","family":"Echevarria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Suter Correia","family":"Cadena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3977-687X","authenticated-orcid":false,"given":"Alexandra","family":"Acco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,10]]},"reference":[{"key":"5970_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.22159\/ijpps.2017v9i8.18774","volume":"9","author":"A Abdualkader","year":"2017","unstructured":"Abdualkader A, Taher M, Yusoff N (2017) Mesoionic sydnone: a review in their chemical and biological properties. Int J Pharm Pharm Sci 9:1. https:\/\/doi.org\/10.22159\/ijpps.2017v9i8.18774","journal-title":"Int J Pharm Pharm Sci"},{"key":"5970_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s43094-021-00216-4","author":"AM Abdualkader","year":"2021","unstructured":"Abdualkader AM, Taher M, Nik Yusoff NI, Alaama M (2021) Discovery of bis-sydnone styryl ketone as a selective cyclooxygenase-2 inhibitor. Future J Pharm Sci. https:\/\/doi.org\/10.1186\/s43094-021-00216-4","journal-title":"Future J Pharm Sci"},{"issue":"6","key":"5970_CR3","doi-asserted-by":"publisher","first-page":"634","DOI":"10.3390\/biomedicines9060634","volume":"9","author":"S Aggarwal","year":"2021","unstructured":"Aggarwal S, Cheng MH, Salvino JM, Bahar I, Mortensen OV (2021) Functional characterization of the dopaminergic psychostimulant sydnocarb as an allosteric modulator of the human dopamine transporter. Biomedicines 9(6):634. https:\/\/doi.org\/10.3390\/biomedicines9060634","journal-title":"Biomedicines"},{"issue":"6","key":"5970_CR4","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1515\/HC.2002.8.6.593","volume":"8","author":"PAA Almeida","year":"2002","unstructured":"Almeida PAA, Silva TMS, Echevarria A (2002) Mesoionic 5-alkyl-1,3-dithiolium-4-thiolates: synthesis and brine shrimp toxicity. Heterocycl Commun 8(6):593\u2013600","journal-title":"Heterocycl Commun"},{"issue":"22","key":"5970_CR5","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1557\/jmr.2012.329","volume":"27","author":"NA Alyoshina","year":"2012","unstructured":"Alyoshina NA, Parfenyuk EV (2012) Effect of surface properties of mesoporous silica on adsorption of mesoionic compound molsidomine. J Mater Res 27(22):2858\u20132866. https:\/\/doi.org\/10.1557\/jmr.2012.329","journal-title":"J Mater Res"},{"key":"5970_CR6","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.msec.2014.03.052","volume":"40","author":"NA Alyoshina","year":"2014","unstructured":"Alyoshina NA, Agafonov AV, Parfenyuk EV (2014) Comparative study of adsorption capacity of mesoporous silica materials for molsidomine: effects of functionalizing and solution pH. Mater Sci Eng C Mater Biol Appl 40:164\u2013171. https:\/\/doi.org\/10.1016\/j.msec.2014.03.052","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"5970_CR7","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ejphar.2015.12.004","volume":"770","author":"ADR Andrade Pires","year":"2016","unstructured":"Andrade Pires ADR, Jabor Gozzi G, Rodrigues Noleto G, Echevarria A, Moretto Reis C, Merlin Rocha ME, Regina Martinez G, Correia Cadena SMS (2016) Antioxidant effect of 1,3,4-thiadiazolium mesoionic derivatives on isolated mitochondria. Eur J Pharmacol 770:78\u201384. https:\/\/doi.org\/10.1016\/j.ejphar.2015.12.004","journal-title":"Eur J Pharmacol"},{"key":"5970_CR8","doi-asserted-by":"publisher","DOI":"10.3164\/jcbn.17.73","author":"RJ Anto","year":"1994","unstructured":"Anto RJ, Kuttan G, Kuttan R, Sathyanarayana K, Rao MNA (1994) Tumor-reducing and antioxidant activities of sydnone-substituted chalcones. J Clin Biochem Nutr. https:\/\/doi.org\/10.3164\/jcbn.17.73","journal-title":"J Clin Biochem Nutr"},{"key":"5970_CR9","doi-asserted-by":"publisher","unstructured":"Barbosa IR, Echevarria A (2022) A brief review of sydnone heterocyclic ring synthesis and anti-cancer activity of its derivatives. In: Revista Virtual de Quimica (Vol. 14, Number 6, pp. 1034\u20131046). Sociedade Brasileira de Quimica. https:\/\/doi.org\/10.21577\/1984-6835.20220058","DOI":"10.21577\/1984-6835.20220058"},{"issue":"10","key":"5970_CR10","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1016\/J.JINORGBIO.2004.05.011","volume":"98","author":"PJ Barnard","year":"2004","unstructured":"Barnard PJ, Baker MV, Berners-Price SJ, Day DA (2004) Mitochondrial permeability transition induced by dinuclear gold(I)\u2013carbene complexes: potential new antimitochondrial antitumour agents. J Inorg Biochem 98(10):1642\u20131647. https:\/\/doi.org\/10.1016\/J.JINORGBIO.2004.05.011","journal-title":"J Inorg Biochem"},{"issue":"1","key":"5970_CR11","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1196\/ANNALS.1369.061;WGROUP:STRING:PUBLICATION","volume":"1074","author":"V Bashkatova","year":"2006","unstructured":"Bashkatova V, Meunier J, Vanin A, Maurice T (2006) Nitric oxide and oxidative stress in the brain of rats exposed in utero to cocaine. Ann N Y Acad Sci 1074(1):632\u2013642. https:\/\/doi.org\/10.1196\/ANNALS.1369.061;WGROUP:STRING:PUBLICATION","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"5970_CR12","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3934\/NEUROSCIENCE.2019.3.191","volume":"6","author":"V Bashkatova","year":"2019","unstructured":"Bashkatova V, Philippu A, Bashkatova V, Philippu A (2019) Role of nitric oxide in psychostimulant-induced neurotoxicity. AIMS Neurosci 6(3):191\u2013203. https:\/\/doi.org\/10.3934\/NEUROSCIENCE.2019.3.191","journal-title":"AIMS Neurosci"},{"issue":"27","key":"5970_CR13","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1039\/d4cc00490f","volume":"60","author":"J Baudet","year":"2024","unstructured":"Baudet J, Lesur E, Rib\u00e9raud M, Chevalier A, D\u2019Anfray T, Thu\u00e9ry P, Audisio D, Taran F (2024) Synthesis of sydnonimines from sydnones and their use for bioorthogonal release of isocyanates in cells. Chem Commun 60(27):3657\u20133660. https:\/\/doi.org\/10.1039\/d4cc00490f","journal-title":"Chem Commun"},{"issue":"9","key":"5970_CR14","doi-asserted-by":"publisher","first-page":"5505","DOI":"10.1021\/acs.chemrev.3c00705","volume":"124","author":"MA Beach","year":"2024","unstructured":"Beach MA, Nayanathara U, Gao Y, Zhang C, Xiong Y, Wang Y, Such GK (2024) Polymeric nanoparticles for drug delivery. Chem Rev 124(9):5505\u20135616. https:\/\/doi.org\/10.1021\/acs.chemrev.3c00705","journal-title":"Chem Rev"},{"key":"5970_CR15","doi-asserted-by":"publisher","unstructured":"Begum HM, Shen K (2023) Intracellular and microenvironmental regulation of mitochondrial membrane potential in cancer cells. WIREs Mech Dis\u00a015(3). https:\/\/doi.org\/10.1002\/WSBM.1595","DOI":"10.1002\/WSBM.1595"},{"key":"5970_CR16","doi-asserted-by":"publisher","first-page":"4720","DOI":"10.1039\/b907908d","volume":"31","author":"L Benhamou","year":"2009","unstructured":"Benhamou L, C\u00e9sar V, Gornitzka H, Lugan N, Lavigne G (2009) Imidazol-2-ylidene-4-olate: an anionic N-heterocyclic carbene pre-programmed for further derivatization. Chem Commun (Camb) 31:4720\u20134722. https:\/\/doi.org\/10.1039\/b907908d","journal-title":"Chem Commun (Camb)"},{"issue":"9","key":"5970_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/ph18091392","volume":"18","author":"F Benk\u0151","year":"2025","unstructured":"Benk\u0151 F, Krist\u00f3 K, Sov\u00e1ny T (2025) Mesoporous silica nanoparticles as drug delivery systems. Pharmaceuticals (Basel) 18(9):1392. https:\/\/doi.org\/10.3390\/ph18091392","journal-title":"Pharmaceuticals (Basel)"},{"issue":"38","key":"5970_CR18","doi-asserted-by":"publisher","first-page":"12892","DOI":"10.1002\/CHEM.201301093;WGROUP:STRING:PUBLICATION","volume":"19","author":"JC Bernhammer","year":"2013","unstructured":"Bernhammer JC, Frison G, Huynh HV (2013) Electronic structure trends in N-heterocyclic carbenes (NHCs) with varying number of nitrogen atoms and NHC-transition-metal bond properties. Chem Eur J 19(38):12892\u201312905. https:\/\/doi.org\/10.1002\/CHEM.201301093;WGROUP:STRING:PUBLICATION","journal-title":"Chem Eur J"},{"key":"5970_CR19","unstructured":"Bhosale SK, Deshpande SR, Wagh RD (2015) Design, synthesis and cytotoxic activity evaluation of mesoionic 4-methoxyphenyl sydnone analogs against 60 human tumors cell lines. In: Scholars Research Library Der Pharma Chemica 7(5). http:\/\/derpharmachemica.com\/archive.html. Accessed Jul 2026"},{"issue":"2","key":"5970_CR20","doi-asserted-by":"publisher","first-page":"513","DOI":"10.36721\/pjps\/30\/2\/02.03.2017\/3930\/513-520","volume":"30","author":"SK Bhosale","year":"2017","unstructured":"Bhosale SK, Deshpande SR, Wagh RD (2017) 3-(4-chlorophenyl)- oxadiazol-3-ium-5-olate and its 4-formyl analog-ultrasound assisted synthesis and in-vitro anticancer evaluation against human tumor cell lines. Pak J Pharm Sci 30(2):513\u2013520. https:\/\/doi.org\/10.36721\/pjps\/30\/2\/02.03.2017\/3930\/513-520","journal-title":"Pak J Pharm Sci"},{"key":"5970_CR21","unstructured":"Bhosale SK, Deshpande SR, Shindea NV (2019) A review on antioxidant activities of sydnone derivatives. Available Online Www.Jocpr.Com. J Chem Pharm Res\u00a011(10):56\u201367. www.jocpr.com"},{"issue":"20","key":"5970_CR22","doi-asserted-by":"publisher","first-page":"4565","DOI":"10.1158\/0008-5472.CAN-19-3588","volume":"80","author":"B Bishal Paudel","year":"2020","unstructured":"Bishal Paudel B, Lewis JE, Hardeman KN, Hayford CE, Robbins CJ, Stauffer PE, Codreanu SG, Sherrod SD, McLean JA, Kemp ML, Quaranta V (2020) An integrative gene expression and mathematical flux balance analysis identifies targetable redox vulnerabilities in melanoma cells. Cancer Res 80(20):4565\u20134577. https:\/\/doi.org\/10.1158\/0008-5472.CAN-19-3588","journal-title":"Cancer Res"},{"issue":"1\u20132","key":"5970_CR23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11010-011-1038-4","volume":"360","author":"EL Bizetto","year":"2012","unstructured":"Bizetto EL, Noleto GR, Echevarria A, Canuto AV, Cadena SMSC (2012) Effect of sydnone SYD-1 on certain functions of LPS-stimulated macrophages. Mol Cell Biochem 360(1\u20132):15\u201321. https:\/\/doi.org\/10.1007\/s11010-011-1038-4","journal-title":"Mol Cell Biochem"},{"key":"5970_CR24","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.cbi.2016.07.007","volume":"256","author":"AP Brandt","year":"2016","unstructured":"Brandt AP, Gozzi GJ, Pires A, Martinez GR, dos Santos Canuto AV, Echevarria A, Di Pietro A, Cadena SMSC (2016) Impairment of oxidative phosphorylation increases the toxicity of SYD-1 on hepatocarcinoma cells (HepG2). Chem Biol Interact 256:154\u2013160. https:\/\/doi.org\/10.1016\/j.cbi.2016.07.007","journal-title":"Chem Biol Interact"},{"key":"5970_CR25","doi-asserted-by":"publisher","unstructured":"Brandt AP, Pires A doR, Rocha ME, Noleto GR, Acco A, de Souza CE, Echevarria A, Canuto AV, Cadena SM (2014) Sydnone SYD-1 affects the metabolic functions of isolated rat hepatocytes. Chem Biol Interact 218:107\u2013114. https:\/\/doi.org\/10.1016\/j.cbi.2014.05.002","DOI":"10.1016\/j.cbi.2014.05.002"},{"issue":"24","key":"5970_CR26","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1002\/cmdc.201800567","volume":"13","author":"AW Brown","year":"2018","unstructured":"Brown AW, Holmes T, Fisher M, Tozer GM, Harrity JPA, Kanthou C (2018) Evaluation of sydnone-based analogues of combretastatin A-4 phosphate (CA4P) as vascular disrupting agents for use in cancer therapy. ChemMedChem 13(24):2618\u20132626. https:\/\/doi.org\/10.1002\/cmdc.201800567","journal-title":"ChemMedChem"},{"issue":"3","key":"5970_CR27","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.tet.2009.10.085","volume":"66","author":"DL Browne","year":"2010","unstructured":"Browne DL, Harrity JPA (2010) Recent developments in the chemistry of sydnones. Tetrahedron 66(3):553\u2013568. https:\/\/doi.org\/10.1016\/j.tet.2009.10.085","journal-title":"Tetrahedron"},{"key":"5970_CR28","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.3762\/BJOC.7.196","volume":"7","author":"K Butkovi\u0107","year":"2011","unstructured":"Butkovi\u0107 K, Marini\u0107 \u017d, Mol\u010danov K, Koji\u0107-Prodi\u0107 B, \u0160indler-Kulyk M (2011) Photochemical and thermal intramolecular 1,3-dipolar cycloaddition reactions of new o-stilbenemethylene-3-sydnones and their synthesis. Beilstein J Org Chem 7:1663\u20131670. https:\/\/doi.org\/10.3762\/BJOC.7.196","journal-title":"Beilstein J Org Chem"},{"issue":"1\u20132","key":"5970_CR29","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/S0014-5793(98)01427-6","volume":"440","author":"SMSC Cadena","year":"1998","unstructured":"Cadena SMSC, Carnieri EGS, Echevarria A, De Oliveira MBM (1998) Effect of MI-D, a new mesoionic compound, on energy-linked functions of rat liver mitochondria. FEBS Lett 440(1\u20132):46\u201350. https:\/\/doi.org\/10.1016\/S0014-5793(98)01427-6","journal-title":"FEBS Lett"},{"issue":"1","key":"5970_CR30","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/CBF.932","volume":"20","author":"SMSC Cadena","year":"2002","unstructured":"Cadena SMSC, Carnieri EGS, Echevarria A, De Oliveira MBM (2002) Interference of MI-D, a new mesoionic compound, on artificial and native membranes. Cell Biochem Funct 20(1):31\u201337. https:\/\/doi.org\/10.1002\/CBF.932","journal-title":"Cell Biochem Funct"},{"issue":"13","key":"5970_CR31","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.2174\/13895575112091359","volume":"12","author":"R Chandrasekhar","year":"2012","unstructured":"Chandrasekhar R, Nanjan MJ (2012) Sydnones: a brief review. Mini Rev Med Chem 12(13):1359\u20131365. https:\/\/doi.org\/10.2174\/13895575112091359","journal-title":"Mini Rev Med Chem"},{"key":"5970_CR32","doi-asserted-by":"publisher","unstructured":"Chaves OA, Echevarria-Lima J, Serpa C, Echevarria \u00c1 (2025) Antitumoral profile of 1,3,4-thiadiazolium salts: insights into a combinatory therapeutic approach with flavonoid quercetin. Chem Biodivers\u00a022(12). https:\/\/doi.org\/10.1002\/cbdv.202501903","DOI":"10.1002\/cbdv.202501903"},{"key":"5970_CR33","unstructured":"Chialera J, Gruner J, Reaume AG, Saporito MS (2018) The method for treating dyskinesia and associated conditions (Chinese Patent No. CN 105209445 B). China National Intellectual Property Administration. https:\/\/patents.google.com\/patent\/CN105209445B\/en"},{"issue":"8","key":"5970_CR34","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1007\/s11010-022-04423-2","volume":"477","author":"ML Corr\u00eaa-Ferreira","year":"2022","unstructured":"Corr\u00eaa-Ferreira ML, do Rocio Andrade Pires A, Barbosa IR, Echevarria A, Pedrassoli GH, Winnischofer SMB, Noleto GR, Cadena SMSC (2022) The mesoionic compound MI-D changes energy metabolism and induces apoptosis in T98G glioma cells. Mol Cell Biochem 477(8):2033\u20132045. https:\/\/doi.org\/10.1007\/s11010-022-04423-2","journal-title":"Mol Cell Biochem"},{"issue":"6","key":"5970_CR35","doi-asserted-by":"publisher","first-page":"411","DOI":"10.2174\/0118715206329159241010052746","volume":"25","author":"ML Corr\u00eaa-Ferreira","year":"2025","unstructured":"Corr\u00eaa-Ferreira ML, do Rocio Andrade Pires A, Miranda JV, de Freitas Montin E, Barbosa IR, Lima AEAN, Rocha MEM, Martinez GR, Cadena SMSC (2025) The mesoionic 1,3,4-thiadiazolium derivative, MI-D, is a potential drug for treating glioblastoma by impairing mitochondrial functions linked to energy provision in glioma cells. Anti-Cancer Agents Med Chem 25(6):411\u2013419. https:\/\/doi.org\/10.2174\/0118715206329159241010052746","journal-title":"Anti-Cancer Agents Med Chem"},{"key":"5970_CR36","doi-asserted-by":"publisher","unstructured":"Costa M, Harmon AC, Coelho Teixeira AA, Ara\u00fajo S, Piero FD, Souza S, Filho A, Junior SA, Maia MD, Wischral A, Gomes Filho MA, Mathis JM (2020) Cytotoxic activity of the mesoionic compound MIH 2.4Bl in breast cancer cell lines. Breast Cancer Basic Clin Res\u00a014:1178223420913330. https:\/\/doi.org\/10.1177\/1178223420913330","DOI":"10.1177\/1178223420913330"},{"issue":"12","key":"5970_CR37","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/S0223-5234(02)01401-0","volume":"37","author":"EF Da Silva","year":"2002","unstructured":"Da Silva EF, Canto-Cavalheiro MM, Braz VR, Cysne-Finkelstein L, Leon LL, Echevarria A (2002) Synthesis, and biological evaluation of new 1,3,4-thiadiazolium-2-phenylamine derivatives against Leishmania amazonensis promastigotes and amastigotes. Eur J Med Chem 37(12):979\u2013984. https:\/\/doi.org\/10.1016\/S0223-5234(02)01401-0","journal-title":"Eur J Med Chem"},{"key":"5970_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25194524","author":"AJ Da Silva Filho","year":"2020","unstructured":"Da Silva Filho AJ, Da Cruz Dantas L, De Santana OL (2020) Diradicalar character and ring stability of mesoionic heterocyclic oxazoles and thiazoles by ab initio mono and multi-reference methods. Molecules. https:\/\/doi.org\/10.3390\/molecules25194524","journal-title":"Molecules"},{"issue":"6","key":"5970_CR39","doi-asserted-by":"publisher","first-page":"2984","DOI":"10.1016\/j.bmc.2007.12.049","volume":"16","author":"W da Silva Ferreira","year":"2008","unstructured":"da Silva Ferreira W, Freire-de-Lima L, Saraiva VB, Alisson-Silva F, Mendon\u00e7a-Previato L, Previato JO, Echevarria A, de Lima MEF (2008) Novel 1,3,4-thiadiazolium-2-phenylamine chlorides derived from natural piperine as trypanocidal agents: chemical and biological studies. Bioorg Med Chem 16(6):2984\u20132991. https:\/\/doi.org\/10.1016\/j.bmc.2007.12.049","journal-title":"Bioorg Med Chem"},{"key":"5970_CR40","doi-asserted-by":"publisher","unstructured":"de Mascena Costa LA, Debnath D, Harmon AC, de Sousa Ara\u00fajo S, da Silva Souza HD, de Athayde Filho PF, Wischral A, Adri\u00e3o Gomes Filho M, Mathis JM (2020) Mechanistic studies of cytotoxic activity of the mesoionic compound MIH 2.4Bl in MCF-7 breast cancer cells. Oncol Lett 20(3):2291\u20132301. https:\/\/doi.org\/10.3892\/ol.2020.11763","DOI":"10.3892\/ol.2020.11763"},{"issue":"8","key":"5970_CR41","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1590\/S0103-50532011000800014","volume":"22","author":"CM Dos Reis","year":"2011","unstructured":"Dos Reis CM, Echevarria-Lima J, Miranda AF, Echevarria A (2011) Improved synthesis of 1,3,4-thiadiazolium-2-phenylamines using microwave and ultrasound irradiation and investigation of their cytotoxic activity. J Braz Chem Soc 22(8):1505\u20131510. https:\/\/doi.org\/10.1590\/S0103-50532011000800014","journal-title":"J Braz Chem Soc"},{"key":"5970_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/J.PARINT.2021.102342","volume":"83","author":"A dos Santos Rosa","year":"2021","unstructured":"dos Santos Rosa A, Frauches-Santos C, Santana RC, Gomes JSC, Lima K, Echevarria A, Saraiva E, Decote-Ricardo D, Atella G, Pinto-da-Silva LH (2021) Leishmanicidal effect of 1,3,4-thiadiazolium mesoionic salts on Leishmania amazonensis in vitro. Parasitol Int 83:102342. https:\/\/doi.org\/10.1016\/J.PARINT.2021.102342","journal-title":"Parasitol Int"},{"key":"5970_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2021.128114","volume":"44","author":"S Du","year":"2021","unstructured":"Du S, Hu X, Shao X, Qian X (2021) Novel trifluoromethyl sydnone derivatives: design, synthesis and fungicidal activity. Bioorg Med Chem Lett 44:128114. https:\/\/doi.org\/10.1016\/j.bmcl.2021.128114","journal-title":"Bioorg Med Chem Lett"},{"issue":"17","key":"5970_CR44","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1016\/S0960-894X(03)00487-6","volume":"13","author":"CS Dunkley","year":"2003","unstructured":"Dunkley CS, Thoman CJ (2003) Synthesis and biological evaluation of a novel phenyl substituted sydnone series as potential antitumor agents. Bioorg Med Chem Lett 13(17):2899\u20132901. https:\/\/doi.org\/10.1016\/S0960-894X(03)00487-6","journal-title":"Bioorg Med Chem Lett"},{"key":"5970_CR45","doi-asserted-by":"publisher","unstructured":"Earl JC, Mackney AW (1935) The action of acetic anhydride on N-nitrosophenylglycine and some of its derivatives. J Chem Soc (Resumed) pp 899\u2013900. https:\/\/doi.org\/10.1039\/jr9350000899","DOI":"10.1039\/jr9350000899"},{"key":"5970_CR46","unstructured":"Erd\u00f6 SL, Kiss B, Rosdy B (1981) Inhibition of dopamine uptake by a new psychostimulant mesocarb (Sydnocarb). Pol J Pharmacol Pharm 33(2):141\u2013147"},{"issue":"8","key":"5970_CR47","doi-asserted-by":"publisher","first-page":"6369","DOI":"10.1007\/s12035-017-0859-x","volume":"55","author":"J Feng","year":"2018","unstructured":"Feng J, Chen X, Guan B, Li C, Qiu J, Shen J (2018) Inhibition of peroxynitrite-induced mitophagy activation attenuates cerebral ischemia-reperfusion injury. Mol Neurobiol 55(8):6369\u20136386. https:\/\/doi.org\/10.1007\/s12035-017-0859-x","journal-title":"Mol Neurobiol"},{"key":"5970_CR48","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/00005344-198906152-00004","volume":"14","author":"M Freelisch","year":"1989","unstructured":"Freelisch M, Ostrowski EN (1989) On the mechanism of NO release from sydnonimines. J Cardiovasc Pharmacol 14:13\u201322","journal-title":"J Cardiovasc Pharmacol"},{"key":"5970_CR49","doi-asserted-by":"publisher","unstructured":"Galuppo, L. F., dos Reis L\u00edvero, F. A., Martins, G. G., Cardoso, C. C., Beltrame, O. C., Klassen, L. M. B., Canuto, A. V. dos S., Echevarria, A., Telles, J. E. Q., Klassen, G., & Acco, A. (2016). Sydnone 1: a mesoionic compound with antitumoral and haematological effects in vivo. Basic & Clinical Pharmacology & Toxicology, 119(1), 41\u201350. https:\/\/doi.org\/10.1111\/BCPT.12545","DOI":"10.1111\/BCPT.12545"},{"issue":"13","key":"5970_CR50","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.3390\/MOLECULES30132770\/S1","volume":"30","author":"J Garc\u00eda de la Concepci\u00f3n","year":"2025","unstructured":"Garc\u00eda de la Concepci\u00f3n J, Cintas P, Mart\u00ednez RF (2025) Understanding bio-orthogonal strain-driven sydnone cycloadditions: data-assisted profiles and the search for linear relationships. Molecules 30(13):2770. https:\/\/doi.org\/10.3390\/MOLECULES30132770\/S1","journal-title":"Molecules"},{"issue":"7\u20138","key":"5970_CR51","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1007\/S10495-025-02123-Y","volume":"30","author":"N Ghosh","year":"2025","unstructured":"Ghosh N, Chatterjee D, Datta A (2025) Tumor heterogeneity and resistance in glioblastoma: the role of stem cells. Apoptosis 30(7\u20138):1695\u20131729. https:\/\/doi.org\/10.1007\/S10495-025-02123-Y","journal-title":"Apoptosis"},{"key":"5970_CR52","doi-asserted-by":"publisher","unstructured":"Glomb T, Szymankiewicz K, \u015awi\u0105tek P (2018) Anti-cancer activity of derivatives of 1,3,4-oxadiazole. In: Molecules (Vol. 23, Number 12). MDPI AG. https:\/\/doi.org\/10.3390\/molecules23123361","DOI":"10.3390\/molecules23123361"},{"issue":"3","key":"5970_CR53","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.cbi.2013.07.004","volume":"205","author":"GJ Gozzi","year":"2013","unstructured":"Gozzi GJ, Pires ADRA, Martinez GR, Rocha MEM, Noleto GR, Echevarria A, Canuto AV, Cadena SMSC (2013) The antioxidant effect of the mesoionic compound SYD-1 in mitochondria. Chem Biol Interact 205(3):181\u2013187. https:\/\/doi.org\/10.1016\/j.cbi.2013.07.004","journal-title":"Chem Biol Interact"},{"key":"5970_CR54","doi-asserted-by":"publisher","unstructured":"Gozzi GJ, Do Rocio Andrade Pires A, Valdameri G, Rocha MEM, Martinez GR, Noleto GR, Acco A, De Souza CEA, Echevarria A, Dos Reis CM, Di Pietro A, Cadena SMSC (2015) Selective cytotoxicity of 1,3,4-thiadiazolium mesoionic derivatives on hepatocarcinoma cells (HepG2). PLoS One\u00a010(6). https:\/\/doi.org\/10.1371\/journal.pone.0130046","DOI":"10.1371\/journal.pone.0130046"},{"issue":"4","key":"5970_CR55","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1021\/JM01239A022","volume":"5","author":"CV Greco","year":"1962","unstructured":"Greco CV, Nyberg WH, Cheng CC (1962) Synthesis of sydnones and sydnone imines. J Med Pharm Chem 5(4):861\u2013865. https:\/\/doi.org\/10.1021\/JM01239A022","journal-title":"J Med Pharm Chem"},{"issue":"3","key":"5970_CR56","doi-asserted-by":"publisher","first-page":"167","DOI":"10.2174\/1381612023396311","volume":"8","author":"R Gryglewski","year":"2002","unstructured":"Gryglewski R, Marcinkiewicz E, Robak J, Michalska Z, Madej J (2002) Mesoionic oxatriazoles (MOTA): NO-donating characteristics and pharmacology. Curr Pharm des 8(3):167\u2013176. https:\/\/doi.org\/10.2174\/1381612023396311","journal-title":"Curr Pharm des"},{"key":"5970_CR57","unstructured":"Grynberg N, Echevarria A, Miller J (1992) Some new aryl-sydnones: effects on murine tumours. Anticancer Res 12(3):1025-8. https:\/\/pubmed.ncbi.nlm.nih.gov\/1320354\/"},{"issue":"1","key":"5970_CR58","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/00001813-199701000-00012","volume":"8","author":"N Grynberg","year":"1997","unstructured":"Grynberg N, Santos AC, Echevarria A (1997) Synthesis and in vivo antitumor activity of new heterocyclic derivatives of the 1,3,4-thiadiazolium-2-aminide class. Anticancer Drugs 8(1):88\u201391. https:\/\/doi.org\/10.1097\/00001813-199701000-00012","journal-title":"Anticancer Drugs"},{"issue":"28","key":"5970_CR59","doi-asserted-by":"publisher","first-page":"4759","DOI":"10.1002\/anie.201001864","volume":"49","author":"G Guisado-Barrios","year":"2010","unstructured":"Guisado-Barrios G, Bouffard J, Donnadieu B, Bertrand G (2010) Crystalline 1H-l,2,3-triazol-5-ylidenes: new stable mesoionic carbenes (MICs). Angewandte Chemie - International Edition 49(28):4759\u20134762. https:\/\/doi.org\/10.1002\/anie.201001864","journal-title":"Angewandte Chemie - International Edition"},{"issue":"12","key":"5970_CR60","doi-asserted-by":"publisher","first-page":"3236","DOI":"10.1021\/ACS.ACCOUNTS.8B00480","volume":"51","author":"G Guisado-Barrios","year":"2018","unstructured":"Guisado-Barrios G, Soleilhavoup M, Bertrand G (2018) 1H\u20131,2,3-triazol-5-ylidenes: readily available mesoionic carbenes. Acc Chem Res 51(12):3236\u20133244. https:\/\/doi.org\/10.1021\/ACS.ACCOUNTS.8B00480","journal-title":"Acc Chem Res"},{"issue":"4","key":"5970_CR61","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1021\/jo00343a024","volume":"47","author":"MJ Haddadin","year":"1982","unstructured":"Haddadin MJ, Kattan AM, Freeman JP (1982) Novel synthesis of the mesoionic system 1,3-oxazolium-4-olate. J Org Chem 47(4):723\u2013725. https:\/\/doi.org\/10.1021\/jo00343a024","journal-title":"J Org Chem"},{"key":"5970_CR62","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ejmech.2014.12.035","volume":"92","author":"S Haider","year":"2015","unstructured":"Haider S, Alam MS, Hamid H (2015) 1,3,4-Thiadiazoles: a potent multi targeted pharmacological scaffold. Eur J Med Chem 92:156\u2013177. https:\/\/doi.org\/10.1016\/j.ejmech.2014.12.035","journal-title":"Eur J Med Chem"},{"issue":"3","key":"5970_CR63","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.cbi.2007.06.003","volume":"169","author":"GC Halila","year":"2007","unstructured":"Halila GC, de Oliveira MBM, Echevarria A, Bel\u00e9m AC, Rocha MEM, Carnieri EGS, Martinez GR, Noleto GR, Cadena SMSC (2007) Effect of sydnone SYD-1, a mesoionic compound, on energy-linked functions of rat liver mitochondria. Chem Biol Interact 169(3):160\u2013170. https:\/\/doi.org\/10.1016\/j.cbi.2007.06.003","journal-title":"Chem Biol Interact"},{"issue":"5","key":"5970_CR64","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1246\/CL.1975.499","volume":"4","author":"M Hamaguchi","year":"1975","unstructured":"Hamaguchi M, Ibata T (1975) New type of mesoionic system. 1,3-dipolar cycloaddition of isomunchnon with ethylenic compounds. Chem Lett 4(5):499\u2013502. https:\/\/doi.org\/10.1246\/CL.1975.499","journal-title":"Chem Lett"},{"key":"5970_CR65","doi-asserted-by":"publisher","unstructured":"Harris IS, Treloar AE, Inoue S, Sasaki M, Gorrini C, Lee KC, Yung KY, Brenner D, Knobbe-Thomsen CB, Cox MA, Elia A, Berger T, Cescon DW, Adeoye A, Br\u00fcstle A, Molyneux SD, Mason JM, Li WY, Yamamoto K, \u2026 Mak TW\u00a0(2015) Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression. Cancer Cell 27(2):211\u2013222. https:\/\/doi.org\/10.1016\/j.ccell.2014.11.019","DOI":"10.1016\/j.ccell.2014.11.019"},{"issue":"1","key":"5970_CR66","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1021\/jm00235a011","volume":"18","author":"JB Hill","year":"1975","unstructured":"Hill JB, Ray RE, Wagner RH, Aspinall RL (1975) Antiinflammatory sydnones. 2. J Med Chem 18(1):50\u201353. https:\/\/doi.org\/10.1021\/jm00235a011","journal-title":"J Med Chem"},{"issue":"1","key":"5970_CR67","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0014-2999(98)00009-0","volume":"346","author":"P Holm","year":"1998","unstructured":"Holm P, Kankaanranta H, Mets\u00e4-Ketel\u00e4 T, Moilanen E (1998) Radical releasing properties of nitric oxide donors GEA 3162, SIN-1 and S-nitroso-N-acetylpenicillamine. Eur J Pharmacol 346(1):97\u2013102. https:\/\/doi.org\/10.1016\/S0014-2999(98)00009-0","journal-title":"Eur J Pharmacol"},{"issue":"9","key":"5970_CR68","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.14233\/ajchem.2021.23297","volume":"33","author":"SL Hossain","year":"2021","unstructured":"Hossain SL, Mathews M, Veerabhadra Swamy BN, Kirankumar B, Yelmaggad CV, Rajendra Singh C (2021) In vitro DNA binding, anticancer and molecular docking studies of new sydnone compounds. Asian J Chem 33(9):2082\u20132092. https:\/\/doi.org\/10.14233\/ajchem.2021.23297","journal-title":"Asian J Chem"},{"issue":"3","key":"5970_CR69","doi-asserted-by":"publisher","first-page":"681","DOI":"10.4103\/jcrt.JCRT_1614_20","volume":"18","author":"SL Hossain","year":"2022","unstructured":"Hossain SL, Mathews M, Nagarajappa VSB, Kumar BK, Yelamaggad CVV, Singh CR (2022) Antiproliferative, apoptosis-inducing activity and molecular docking studies of sydnones compounds. J Cancer Res Ther 18(3):681\u2013690. https:\/\/doi.org\/10.4103\/jcrt.JCRT_1614_20","journal-title":"J Cancer Res Ther"},{"issue":"31","key":"5970_CR70","doi-asserted-by":"publisher","first-page":"5704","DOI":"10.1039\/d5cc00535c","volume":"61","author":"AF Idocin","year":"2025","unstructured":"Idocin AF, Specklin S, Taran F (2025) Sydnonimines: synthesis, properties and applications in chemical biology. Chem Commun 61(31):5704\u20135718. https:\/\/doi.org\/10.1039\/d5cc00535c","journal-title":"Chem Commun"},{"key":"5970_CR71","doi-asserted-by":"crossref","unstructured":"Kalluraya B, Rahiman MA, Banji D (2002) Sydnone derivatives: Part V \u2014 Synthesis and pharmacological properties of some novel triazolothiadiazepines. Indian J Chem - Sect B 41(8):1712\u20131717.\u00a0https:\/\/nopr.niscpr.res.in\/handle\/123456789\/22027","DOI":"10.1002\/chin.200247156"},{"issue":"8\u20139","key":"5970_CR72","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/1521-4184(200109)334:8\/9263::AID-ARDP2633.0.CO;2-N","volume":"334","author":"B Kalluraya","year":"2001","unstructured":"Kalluraya B, Rahiman MA, Banji D (2001) Sydnone derivatives. Part VII: synthesis of some novel thiazoles and their pharmacological properties. Arch Pharm 334(8\u20139):263\u2013268. https:\/\/doi.org\/10.1002\/1521-4184(200109)334:8\/9263::AID-ARDP2633.0.CO;2-N","journal-title":"Arch Pharm"},{"issue":"3","key":"5970_CR73","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/J.1476-5381.1996.TB15204.X","volume":"117","author":"H Kankaanranta","year":"1996","unstructured":"Kankaanranta H, Rydell E, Petersson AS, Holm P, Moilanen E, Corell T, Karup G, Vuorinen P, Pedersen SB, Wennmalm \u00c5, Mets\u00e4-Ketel\u00e4 T (1996) Nitric oxide-donating properties of mesoionic 3-aryl substituted oxatriazole-5-imine derivatives. Br J Pharmacol 117(3):401\u2013406. https:\/\/doi.org\/10.1111\/J.1476-5381.1996.TB15204.X","journal-title":"Br J Pharmacol"},{"key":"5970_CR74","doi-asserted-by":"publisher","unstructured":"Kawase M, Sakagami H, Motohashi N (2007)\u00a0The chemistry of bioactive mesoionic heterocycles.\u00a0pp 135\u2013152. https:\/\/doi.org\/10.1007\/7081_2007_096","DOI":"10.1007\/7081_2007_096"},{"key":"5970_CR75","doi-asserted-by":"publisher","first-page":"97","DOI":"10.20534\/ELBLS-15-3-97-100","volume":"3","author":"EB Kharaponova","year":"2015","unstructured":"Kharaponova EB, Drozdov AL, Silkina YV (2015) Structural and functional changes of mitochondria in rat cardiomyocytes in subacute administration of sydnocarb. European Journal of Biomedical and Life Sciences 3:97\u2013100. https:\/\/doi.org\/10.20534\/ELBLS-15-3-97-100","journal-title":"European Journal of Biomedical and Life Sciences"},{"issue":"11","key":"5970_CR76","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1002\/jps.2600511110","volume":"51","author":"LB Kier","year":"1962","unstructured":"Kier LB, Dhawan D (1962) Synthesis of sydnones as potential therapeutic agents. J Pharm Sci 51(11):1058\u20131061. https:\/\/doi.org\/10.1002\/jps.2600511110","journal-title":"J Pharm Sci"},{"issue":"2","key":"5970_CR77","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/jps.2600560202","volume":"56","author":"LB Kier","year":"1967","unstructured":"Kier LB, Roche EB (1967) Medicinal chemistry of the mesoionic compounds. J Pharm Sci 56(2):149\u2013168. https:\/\/doi.org\/10.1002\/jps.2600560202","journal-title":"J Pharm Sci"},{"issue":"20","key":"5970_CR78","doi-asserted-by":"publisher","first-page":"3974","DOI":"10.1021\/ACS.ORGANOMET.7B00591\/SUPPL_FILE\/OM7B00591_SI_002.XYZ","volume":"36","author":"MA Kinzhalov","year":"2017","unstructured":"Kinzhalov MA, Legkodukh AS, Anisimova TB, Novikov AS, Suslonov VV, Luzyanin KV, Kukushkin VY (2017) Tetrazol-5-ylidene gold(III) complexes from sequential [2 + 3] cycloaddition of azide to metal-bound isocyanides and N4 alkylation. Organometallics 36(20):3974\u20133980. https:\/\/doi.org\/10.1021\/ACS.ORGANOMET.7B00591\/SUPPL_FILE\/OM7B00591_SI_002.XYZ","journal-title":"Organometallics"},{"issue":"8","key":"5970_CR79","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.3390\/polym16081105","volume":"16","author":"S Kovtareva","year":"2024","unstructured":"Kovtareva S, Kusepova L, Tazhkenova G, Mashan T, Bazarbaeva K, Kopishev E (2024) Surface modification of mesoporous silica nanoparticles for application in targeted delivery systems of antitumour drugs. Polymers 16(8):1105. https:\/\/doi.org\/10.3390\/polym16081105","journal-title":"Polymers"},{"issue":"21","key":"5970_CR80","doi-asserted-by":"publisher","first-page":"4082","DOI":"10.1021\/ACS.ORGANOMET.9B00327","volume":"38","author":"J Kralj","year":"2019","unstructured":"Kralj J, Bolje A, Polan\u010dec DS, Steiner I, Gr\u017ean T, Tupek A, Stojanovi\u0107 N, Hohloch S, Urankar D, Osmak M, Sarkar B, Brozovic A, Ko\u0161mrlj J (2019) Half-sandwich Ir(III) and Os(II) complexes of pyridyl-mesoionic carbenes as potential anticancer agents. Organometallics 38(21):4082\u20134092. https:\/\/doi.org\/10.1021\/ACS.ORGANOMET.9B00327","journal-title":"Organometallics"},{"issue":"65","key":"5970_CR81","doi-asserted-by":"publisher","first-page":"16093","DOI":"10.1002\/chem.202103026","volume":"27","author":"K Krell","year":"2021","unstructured":"Krell K, Pfeuffer B, R\u00f6nicke F, Chinoy ZS, Favre C, Friscourt F, Wagenknecht H (2021) Fast and efficient postsynthetic DNA labeling in cells by means of strain\u2010promoted sydnone\u2010alkyne cycloadditions. Chem-Eur J 27(65):16093\u201316097. https:\/\/doi.org\/10.1002\/chem.202103026","journal-title":"Chem-Eur J"},{"issue":"4","key":"5970_CR82","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1039\/B603765H","volume":"36","author":"O K\u00fchl","year":"2006","unstructured":"K\u00fchl O (2006) The chemistry of functionalised N-heterocyclic carbenes. Chem Soc Rev 36(4):592\u2013607. https:\/\/doi.org\/10.1039\/B603765H","journal-title":"Chem Soc Rev"},{"issue":"41","key":"5970_CR83","doi-asserted-by":"publisher","first-page":"14544","DOI":"10.1002\/anie.201908052","volume":"58","author":"RA Kumar","year":"2019","unstructured":"Kumar RA, Pattanayak MR, Yen-Pon E, Eliyan J, Porte K, Bernard S, Riomet M, Thu\u00e9ry P, Audisio D, Taran F (2019) Strain-promoted 1,3-dithiolium-4-olates\u2013alkyne cycloaddition. Angew Chem Int Ed Engl 58(41):14544\u201314548. https:\/\/doi.org\/10.1002\/anie.201908052","journal-title":"Angew Chem Int Ed Engl"},{"issue":"5","key":"5970_CR84","doi-asserted-by":"publisher","DOI":"10.3390\/life13051099","volume":"13","author":"L Kumari","year":"2023","unstructured":"Kumari L, Choudhari Y, Patel P, Gupta GD, Singh D, Rosenholm JM, Bansal KK, Kurmi BD (2023) Advancement in solubilization approaches: a step towards bioavailability enhancement of poorly soluble drugs. Life (Basel, Switzerland) 13(5):1099. https:\/\/doi.org\/10.3390\/life13051099","journal-title":"Life (Basel, Switzerland)"},{"key":"5970_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/J.BMC.2024.117904","volume":"113","author":"L Le Saux","year":"2024","unstructured":"Le Saux L, Haddad F, Gestin JF, Eychenne R, Gu\u00e9rard F (2024) Sydnone-based prosthetic groups for radioiodination. Bioorg Med Chem 113:117904. https:\/\/doi.org\/10.1016\/J.BMC.2024.117904","journal-title":"Bioorg Med Chem"},{"issue":"7","key":"5970_CR86","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1021\/acs.bioconjchem.4c00068","volume":"35","author":"L Lincy-Bianchi","year":"2024","unstructured":"Lincy-Bianchi L, H\u00e4fner M, Becquart C, T\u00e4ngemo C, Kurczy ME, Munier CC, Knerr L (2024) Incorporation of intracellular nanoSIMS tracers to oligonucleotide conjugates via strain promoted sydnone\u2013alkyne cycloaddition. Bioconjug Chem 35(7):912\u2013921. https:\/\/doi.org\/10.1021\/acs.bioconjchem.4c00068","journal-title":"Bioconjug Chem"},{"issue":"5","key":"5970_CR87","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1590\/S0103-50532010000500024","volume":"21","author":"BF Lyra","year":"2010","unstructured":"Lyra BF, de Morais SA, Rocha GB, Miller J, Moura GLC, Simas AM, Peppe C, de Athayde-Filho PF (2010) 1,3-Thiazolium-5-thiolates mesoionic compounds: Semiempirical evaluation of their first static hyperpolarizabilities and synthesis of new examples. J Braz Chem Soc 21(5):934\u2013940. https:\/\/doi.org\/10.1590\/S0103-50532010000500024","journal-title":"J Braz Chem Soc"},{"issue":"19","key":"5970_CR88","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS21196992","volume":"21","author":"S Mani","year":"2020","unstructured":"Mani S, Swargiary G, Singh KK (2020) Natural agents targeting mitochondria in cancer. Int J Mol Sci 21(19):6992. https:\/\/doi.org\/10.3390\/IJMS21196992","journal-title":"Int J Mol Sci"},{"issue":"25","key":"5970_CR89","doi-asserted-by":"publisher","first-page":"4264","DOI":"10.1039\/d5ce00334b","volume":"27","author":"MAP Martins","year":"2025","unstructured":"Martins MAP, Orlando T, Rosa JML, Lima P, Salbego P (2025) Evaluation of mesoionic compound aromaticity using the HOMHED index. CrystEngComm 27(25):4264\u20134273. https:\/\/doi.org\/10.1039\/d5ce00334b","journal-title":"CrystEngComm"},{"issue":"3","key":"5970_CR90","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/B978-008096518-5.00069-1","volume":"1982\u20131995","author":"DM McKinnon","year":"1996","unstructured":"McKinnon DM (1996) 1,2-Dithioles. Comprehensive Heterocyclic Chemistry II: a Review of the Literature 1982\u20131995(3):569\u2013605. https:\/\/doi.org\/10.1016\/B978-008096518-5.00069-1","journal-title":"Comprehensive Heterocyclic Chemistry II: a Review of the Literature"},{"issue":"9","key":"5970_CR91","first-page":"655","volume":"10","author":"JA Melendez","year":"1999","unstructured":"Melendez JA, Melathe RP, Rodriguez AM, Mazurkiewicz JE, Davies KJ (1999) Nitric oxide enhances the manganese superoxide dismutase-dependent suppression of proliferation in HT-1080 fibrosarcoma cells. Cell Growth & Differentiation\u202f: the Molecular Biology Journal of the American Association for Cancer Research 10(9):655\u2013664","journal-title":"Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research"},{"issue":"2","key":"5970_CR92","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/0167-5273(83)90029-3","volume":"3","author":"R Messin","year":"1983","unstructured":"Messin R, Demaret B, Denolin H (1983) Effects of molsidomine on exercise tolerance in patients with coronary heart disease. Int J Cardiol 3(2):137\u2013144. https:\/\/doi.org\/10.1016\/0167-5273(83)90029-3","journal-title":"Int J Cardiol"},{"issue":"1","key":"5970_CR93","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ijcard.2004.01.007","volume":"98","author":"R Messin","year":"2005","unstructured":"Messin R, Opolski G, Fenyvesi T, Carreer-Bruhwyler F, Dubois C, Famaey JP, G\u00e9czy J (2005) Efficacy and safety of molsidomine once-a-day in patients with stable angina pectoris. Int J Cardiol 98(1):79\u201389. https:\/\/doi.org\/10.1016\/j.ijcard.2004.01.007","journal-title":"Int J Cardiol"},{"issue":"21","key":"5970_CR94","doi-asserted-by":"publisher","first-page":"7533","DOI":"10.3390\/app10217533","volume":"10","author":"M Mirzaei","year":"2020","unstructured":"Mirzaei M, Zarch MB, Darroudi M, Sayyadi K, Keshavarz ST, Sayyadi J, Fallah A, Maleki H (2020) Silica mesoporous structures: effective nanocarriers in drug delivery and nanocatalysts. Appl Sci 10(21):7533. https:\/\/doi.org\/10.3390\/app10217533","journal-title":"Appl Sci"},{"issue":"1\u20132","key":"5970_CR95","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0169-409X(01)00125-9","volume":"49","author":"JS Modica-Napolitano","year":"2001","unstructured":"Modica-Napolitano JS, Aprille JR (2001) Delocalized lipophilic cations selectively target the mitochondria of carcinoma cells. Adv Drug Deliv Rev 49(1\u20132):63\u201370. https:\/\/doi.org\/10.1016\/S0169-409X(01)00125-9","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"5970_CR96","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1080\/10715762.2025.2485219","volume":"59","author":"APP Neves","year":"2025","unstructured":"Neves APP, Kaziuk FD, Corr\u00eaa-Ferreira ML, Martinez GR, Mazepa E, Sousa-Pereira D, Echevarria A, Brochado Winnischofer SM, Andrade Pires AdoR, Cadena SMSC (2025) Oxidative imbalance linked to impaired mitochondrial bioenergetics mediates the toxicity of mesoionic compounds MI-D and MI-J in hepatocarcinoma cells (HepG2). Free Radic Res 59(4):308\u2013320. https:\/\/doi.org\/10.1080\/10715762.2025.2485219","journal-title":"Free Radic Res"},{"issue":"20","key":"5970_CR97","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.1016\/0040-4020(82)80186-5","volume":"38","author":"CG Newton","year":"1982","unstructured":"Newton CG, Ramsden CA (1982) Meso-ionic heterocycles (1976\u20131980). Tetrahedron 38(20):2965\u20133011. https:\/\/doi.org\/10.1016\/0040-4020(82)80186-5","journal-title":"Tetrahedron"},{"key":"5970_CR98","doi-asserted-by":"publisher","unstructured":"Newton CG, Ollis WD, Rowson GP, Hamor MJ, Hamor TA (1992) Cyclic meso-ionic heterocycles. Part 24. The reaction of 1,2-dithiolium-4-olates with aniline. The formationof 11-phenylbenz[b]indeno[2,1-e]-1,4-thiazine. Tetrahedron\u00a048(37):8127\u20138142. https:\/\/doi.org\/10.1016\/S0040-4020(01)80482-8","DOI":"10.1016\/S0040-4020(01)80482-8"},{"issue":"2","key":"5970_CR99","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.bmc.2013.12.014","volume":"22","author":"A Nortcliffe","year":"2014","unstructured":"Nortcliffe A, Ekstrom AG, Black JR, Ross JA, Habib FK, Botting NP, O\u2019Hagan D (2014) Synthesis and biological evaluation of nitric oxide-donating analogues of sulindac for prostate cancer treatment. Bioorg Med Chem 22(2):756\u2013761. https:\/\/doi.org\/10.1016\/j.bmc.2013.12.014","journal-title":"Bioorg Med Chem"},{"key":"5970_CR100","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2023.110796","author":"R Oliveira","year":"2024","unstructured":"Oliveira R, Stoltz IR, Gon\u00e7alves PG, Echevarria A, Taborda L, Lepinsk Lopes RH, Pereira LF, Elifio-Esposito S (2024) Evaluation of the antitumoral effects of the mesoionic compound MI-D: implications for endothelial cells viability and angiogenesis inhibition. Chem Biol Interact. https:\/\/doi.org\/10.1016\/j.cbi.2023.110796","journal-title":"Chem Biol Interact"},{"key":"5970_CR101","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/BS.AIHCH.2021.11.001","volume":"137","author":"WD Ollis","year":"2022","unstructured":"Ollis WD, Ramsden CA (2022) Meso-ionic compounds. Adv Heterocycl Chem 137:229\u2013347. https:\/\/doi.org\/10.1016\/BS.AIHCH.2021.11.001","journal-title":"Adv Heterocycl Chem"},{"issue":"1","key":"5970_CR102","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1152\/PHYSREV.00029.2006","volume":"87","author":"P Pacher","year":"2007","unstructured":"Pacher P, Beckman JS, Liaudet L (2007) Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87(1):315. https:\/\/doi.org\/10.1152\/PHYSREV.00029.2006","journal-title":"Physiol Rev"},{"key":"5970_CR103","doi-asserted-by":"publisher","unstructured":"Pereira RA, Pires A do R A, Echevarria A, Sousa-Pereira D, Noleto GR, Suter Correia Cadena SM (2021) The toxicity of 1,3,4-thiadiazolium mesoionic derivatives on hepatocarcinoma cells (HepG2) is associated with mitochondrial dysfunction. Chem Biol Interacti\u00a0349. https:\/\/doi.org\/10.1016\/j.cbi.2021.109675","DOI":"10.1016\/j.cbi.2021.109675"},{"issue":"1","key":"5970_CR104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cbi.2010.04.001","volume":"186","author":"A Pires","year":"2010","unstructured":"Pires A, de Oliveira MBM, Echevarria A, Silva EF, Rocha MEM, Carnieri EGS, Martinez GR, Noleto GR, Cadena SMSC (2010) Comparative study of the effects of 1,3,4-thiadiazolium mesoionic derivatives on energy-linked functions of rat liver mitochondria. Chem Biol Interact 186(1):1\u20138. https:\/\/doi.org\/10.1016\/j.cbi.2010.04.001","journal-title":"Chem Biol Interact"},{"key":"5970_CR105","doi-asserted-by":"publisher","unstructured":"Pires A do R A, Noleto GR, Echevarria A, Dos Reis CM, Carnieri EGS, Martinez GR, Cadena SMSC (2011) Interaction of 1,3,4-thiadiazolium mesoionic derivatives with mitochondrial membrane and scavenging activity: Involvement of their effects on mitochondrial energy-linked functions. Chem Biol Interact\u00a0189(1\u20132):17\u201325. https:\/\/doi.org\/10.1016\/J.CBI.2010.09.030","DOI":"10.1016\/J.CBI.2010.09.030"},{"issue":"12","key":"5970_CR106","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.3390\/ANTIOX10121942","volume":"10","author":"S Pizzimenti","year":"2021","unstructured":"Pizzimenti S, Ribero S, Cucci MA, Grattarola M, Monge C, Dianzani C, Barrera G, Muzio G (2021) Oxidative stress-related mechanisms in melanoma and in the acquired resistance to targeted therapies. Antioxidants (Basel) 10(12):1942. https:\/\/doi.org\/10.3390\/ANTIOX10121942","journal-title":"Antioxidants (Basel)"},{"issue":"31","key":"5970_CR107","doi-asserted-by":"publisher","first-page":"4582","DOI":"10.1039\/c9cc01458f","volume":"55","author":"L Plougastel","year":"2019","unstructured":"Plougastel L, Pattanayak MR, Riomet M, Bregant S, Sallustrau A, Nothisen M, Wagner A, Audisio D, Taran F (2019) Sydnone-based turn-on fluorogenic probes for no-wash protein labeling and in-cell imaging. Chem Commun (Camb) 55(31):4582\u20134585. https:\/\/doi.org\/10.1039\/c9cc01458f","journal-title":"Chem Commun (Camb)"},{"issue":"12","key":"5970_CR108","doi-asserted-by":"publisher","first-page":"6718","DOI":"10.1021\/acs.chemrev.0c00806","volume":"121","author":"K Porte","year":"2021","unstructured":"Porte K, Riomet M, Figliola C, Audisio D, Taran F (2021) Click and bio-orthogonal reactions with mesoionic compounds. Chem Rev Am Chem Soc 121(12):6718\u20136743. https:\/\/doi.org\/10.1021\/acs.chemrev.0c00806","journal-title":"Chem Rev Am Chem Soc"},{"issue":"11","key":"5970_CR109","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/S0891-5849(02)01111-5","volume":"33","author":"R Radi","year":"2002","unstructured":"Radi R, Cassina A, Hodara R, Quijano C, Castro L (2002) Peroxynitrite reactions and formation in mitochondria. Free Radic Biol Med 33(11):1451\u20131464. https:\/\/doi.org\/10.1016\/S0891-5849(02)01111-5","journal-title":"Free Radic Biol Med"},{"key":"5970_CR110","unstructured":"Ramsden CA (2022) Heterocyclic mesomeric betaines and mesoionic compounds"},{"issue":"9","key":"5970_CR111","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.202400697","volume":"20","author":"I Resendes-Barbosa","year":"2025","unstructured":"Resendes-Barbosa I, Alves Amorim M, de Souza Oliveira VH, Andr\u00e9 E, Pereira Guedes G, Augusto Chaves O, Serpa C, Fintelman-Rodrigues N, Sacramento CQ, Moreno L. Souza T, Sant\u2019Anna CMR, Echevarria A (2025) Novel sulfonamide-sydnone hybrids: complementary insight into anti-inflammatory action, anti-SARS-CoV-2 activity, human serum albumin interaction, and in silico analysis. ChemMedChem 20(9):e202400697. https:\/\/doi.org\/10.1002\/cmdc.202400697","journal-title":"ChemMedChem"},{"key":"5970_CR112","doi-asserted-by":"publisher","unstructured":"Rodrigues RF, da Silva EF, \u00c1urea Echevarria Fajardo-Bonin R, Amaral VF, Leon LL, Canto-Cavalheiro MM (2007) A comparative study of mesoionic compounds in Leishmania sp. and toxicity evaluation. Eur J Med Chem\u00a042(7):1039\u20131043. https:\/\/doi.org\/10.1016\/J.EJMECH.2006.12.026","DOI":"10.1016\/J.EJMECH.2006.12.026"},{"issue":"2","key":"5970_CR113","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1128\/AAC.00062-08","volume":"53","author":"RF Rodrigues","year":"2009","unstructured":"Rodrigues RF, Charret KS, Da Silva EF, Echevarria \u00c1, Amaral VF, Leon LL, Canto-Cavalheiro MM (2009) Antileishmanial activity of 1,3,4-thiadiazolium-2-aminide in mice infected with Leishmania amazonensis. Antimicrob Agents Chemother 53(2):839\u2013842. https:\/\/doi.org\/10.1128\/AAC.00062-08","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"5970_CR114","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1016\/j.bmc.2012.01.009","volume":"20","author":"RF Rodrigues","year":"2012","unstructured":"Rodrigues RF, Castro-Pinto D, Echevarria A, Dos Reis CM, Del Cistia CN, Sant\u2019Anna CMR, Teixeira F, Castro H, Canto-Cavalheiro M, Leon LL, Tom\u00e1s A (2012) Investigation of trypanothione reductase inhibitory activity by 1,3,4-thiadiazolium-2-aminide derivatives and molecular docking studies. Bioorg Med Chem 20(5):1760\u20131766. https:\/\/doi.org\/10.1016\/j.bmc.2012.01.009","journal-title":"Bioorg Med Chem"},{"key":"5970_CR115","unstructured":"Satyanarayana K (1993) Synthesis and antiinflammatory, analgesic, and antipyretic testing of 4~[1-Oxo-(3-substituted aryl)-2-propenyl]-3-phenylsydnones and of 3-[4-[3-( Su bst ituted ary 1)-I-oxo-2-propenyl]phenyl]sydnones"},{"issue":"7\u20138","key":"5970_CR116","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/0223-5234(96)88280-8","volume":"30","author":"K Satyanarayana","year":"1995","unstructured":"Satyanarayana K, Rao M (1995a) Synthesis of 4-[5-(substituted aryl)-4,5-dihydro-1H-pyrazol-3-yl]-3-phenyl-sydnones as antiinflammatory, antiarthritic and analgesic agents. Eur J Med Chem 30(7\u20138):641\u2013645. https:\/\/doi.org\/10.1016\/0223-5234(96)88280-8","journal-title":"Eur J Med Chem"},{"issue":"2","key":"5970_CR117","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/jps.2600840228","volume":"84","author":"K Satyanarayana","year":"1995","unstructured":"Satyanarayana K, Rao MNA (1995b) Synthesis and antiinflammatory, analgesic, and antipyretic testing of 4\u2010[1\u2010oxo\u2010(3\u2010substituted aryl)\u20102\u2010propenyl]\u20103\u2010phenylsydnones and of 3\u2010[4\u2010[3\u2010(substituted aryl)\u20101\u2010oxo\u20102\u2010propenyl]phenyl]sydnones. J Pharm Sci 84(2):263\u2013266. https:\/\/doi.org\/10.1002\/jps.2600840228","journal-title":"J Pharm Sci"},{"key":"5970_CR118","unstructured":"Satyanarayana K, Deshpande SR, Rao BS, Rao MNA (2004) Anticancer activity of 4-[1-oxo-(substitutedaryl)-2-propenyl]-3-phenylsydnones. Indian J Pharm Sci 66(5):679\u2013683"},{"issue":"21","key":"5970_CR119","doi-asserted-by":"publisher","first-page":"15747","DOI":"10.1021\/ACS.JMEDCHEM.1C01021","volume":"64","author":"JF Schlagintweit","year":"2021","unstructured":"Schlagintweit JF, Jakob CHG, Wilke NL, Ahrweiler M, Frias C, Frias J, K\u00f6nig M, Esslinger EMHJ, Marques F, MacHado JF, Reich RM, Morais TS, Correia JDG, Prokop A, K\u00fchn FE (2021) Gold(I) bis(1,2,3-triazol-5-ylidene) complexes as promising selective anticancer compounds. J Med Chem 64(21):15747\u201315757. https:\/\/doi.org\/10.1021\/ACS.JMEDCHEM.1C01021","journal-title":"J Med Chem"},{"issue":"5","key":"5970_CR120","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1097\/00008390-200310000-00005","volume":"13","author":"A Senff-Ribeiro","year":"2003","unstructured":"Senff-Ribeiro A, Echevarria A, Fernandes Silva E, Sanches Veiga S, Oliveira MBM (2003) Effect of a new 1,3,4-thiadiazolium mesoionic compound (MI-D) on B16-F10 murine melanoma. Melanoma Res 13(5):465\u2013471. https:\/\/doi.org\/10.1097\/00008390-200310000-00005","journal-title":"Melanoma Res"},{"issue":"2","key":"5970_CR121","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/sj.bjc.6601946","volume":"91","author":"A Senff-Ribeiro","year":"2004","unstructured":"Senff-Ribeiro A, Echevarria A, Silva EF, Franco CRC, Veiga SS, Oliveira MBM (2004a) Cytotoxic effect of a new 1,3,4-thiadiazolium mesoionic compound (MI-D) on cell lines of human melanoma. Br J Cancer 91(2):297\u2013304. https:\/\/doi.org\/10.1038\/sj.bjc.6601946","journal-title":"Br J Cancer"},{"issue":"3","key":"5970_CR122","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/00001813-200403000-00012","volume":"15","author":"A Senff-Ribeiro","year":"2004","unstructured":"Senff-Ribeiro A, Echevarria A, Silva ER, Veiga SS, Oliveira MBM (2004b) Antimelanoma activity of 1,3,4-thiadiazolium mesoionics: a structure-activity relationship study. Anticancer Drugs 15(3):269\u2013275. https:\/\/doi.org\/10.1097\/00001813-200403000-00012","journal-title":"Anticancer Drugs"},{"issue":"1","key":"5970_CR123","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/J.EXPPARA.2013.05.008","volume":"135","author":"RJ Soares-Bezerra","year":"2013","unstructured":"Soares-Bezerra RJ, Leon LL, Echevarria A, Reis CM, Gomes-Silva L, Agostinho CG, Fernandes RA, Canto-Cavalheiro MM, Genestra MS (2013) In vitro evaluation of 4-phenyl-5-(4\u2032-X-phenyl)-1,3,4-thiadiazolium-2-phenylaminide chlorides and 3[N-4\u2032-X-phenyl]-1,2,3-oxadiazolium-5-olate derivatives on nitric oxide synthase and arginase activities of Leishmania amazonensis. Exp Parasitol 135(1):50\u201354. https:\/\/doi.org\/10.1016\/J.EXPPARA.2013.05.008","journal-title":"Exp Parasitol"},{"issue":"6","key":"5970_CR124","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/j.1472-8206.1991.tb00741.x","volume":"5","author":"O Spreux-Varoquaux","year":"1991","unstructured":"Spreux-Varoquaux O, Ulmer B, Cordonnier P, Forestier A, Pays M, Ducreuzet C, Advenier C (1991) Pharmacokinetics of molsidomine and of its active metabolite, SIN-1 (or linsidomine), in the elderly. Fundam Clin Pharmacol 5(6):549\u2013556. https:\/\/doi.org\/10.1111\/j.1472-8206.1991.tb00741.x","journal-title":"Fundam Clin Pharmacol"},{"issue":"5","key":"5970_CR125","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1002\/JPS.2600540515","volume":"54","author":"TG Stewart","year":"1965","unstructured":"Stewart TG, Kier LB (1965) Synthesis of several mesoionic 1,3,4-thiadiazoles. J Pharm Sci 54(5):731\u2013734. https:\/\/doi.org\/10.1002\/JPS.2600540515","journal-title":"J Pharm Sci"},{"issue":"16","key":"5970_CR126","doi-asserted-by":"publisher","first-page":"8915","DOI":"10.1021\/ACS.INORGCHEM.6C00049","volume":"65","author":"S Stifel","year":"2026","unstructured":"Stifel S, Schmidt C, Richter LF, P\u00f6thig A, Casini A, K\u00fchn FE (2026) Tetrazolylidene-stabilized Gold(I) complexes: synthesis and evaluation of anticancer activity in vitro. Inorg Chem 65(16):8915. https:\/\/doi.org\/10.1021\/ACS.INORGCHEM.6C00049","journal-title":"Inorg Chem"},{"key":"5970_CR127","doi-asserted-by":"publisher","unstructured":"Szeliga M, Karpi\u0144ska M, Rola R, Niewiadomy A (2020) Design, synthesis and biological evaluation of novel 1,3,4-thiadiazole derivatives as anti-glioblastoma agents targeting the AKT pathway. Bioorg Chem\u00a0105. https:\/\/doi.org\/10.1016\/J.BIOORG.2020.104362","DOI":"10.1016\/J.BIOORG.2020.104362"},{"issue":"1","key":"5970_CR128","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/SJ.BJP.0705909","volume":"143","author":"EL Taylor","year":"2004","unstructured":"Taylor EL, Rossi AG, Shaw CA, Dal Rio FP, Haslett C, Megson IL (2004) GEA 3162 decomposes to co-generate nitric oxide and superoxide and induces apoptosis in human neutrophils via a peroxynitrite-dependent mechanism. Br J Pharmacol 143(1):179\u2013185. https:\/\/doi.org\/10.1038\/SJ.BJP.0705909","journal-title":"Br J Pharmacol"},{"issue":"9","key":"5970_CR129","doi-asserted-by":"publisher","first-page":"4367","DOI":"10.1007\/s00044-012-0441-z","volume":"22","author":"G Tegginamath","year":"2013","unstructured":"Tegginamath G, Kamble RR, Taj T, Kattimani PP, Meti GY (2013) Synthesis of novel imidazo[2,1-b][1,3,4]thiadiazoles appended to sydnone as anticancer agents. Med Chem Res 22(9):4367\u20134375. https:\/\/doi.org\/10.1007\/s00044-012-0441-z","journal-title":"Med Chem Res"},{"key":"5970_CR130","doi-asserted-by":"publisher","unstructured":"Thanh ND, Duc HT, Duyen VT, Tuong PM, Quoc N (2015) Synthesis and antibacterial and antifungal activities of N-(tetra-O-acetyl-\u03b2-d-glucopyranosyl)thiosemicarbazones of substituted 4-formylsydnones. Chem Cent J\u00a09(1). https:\/\/doi.org\/10.1186\/s13065-015-0138-8","DOI":"10.1186\/s13065-015-0138-8"},{"issue":"29","key":"5970_CR131","doi-asserted-by":"publisher","DOI":"10.1002\/EJIC.202500382;WGROUP:STRING:PUBLICATION","volume":"28","author":"G Tonon","year":"2025","unstructured":"Tonon G, Scianna M, Caligiuri I, Rizzolio F, Visentin F, Scattolin T (2025) Mannose-inspired mesoionic carbenes: building antitumor palladium(II) allyl complexes. Eur J Inorg Chem 28(29):e202500382. https:\/\/doi.org\/10.1002\/EJIC.202500382;WGROUP:STRING:PUBLICATION","journal-title":"Eur J Inorg Chem"},{"issue":"3","key":"5970_CR132","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1111\/cbdd.13795","volume":"97","author":"A Vaidya","year":"2021","unstructured":"Vaidya A, Pathak D, Shah K (2021) 1,3,4-oxadiazole and its derivatives: a review on recent progress in anticancer activities. Chem Biol Drug des 97(3):572\u2013591. https:\/\/doi.org\/10.1111\/cbdd.13795","journal-title":"Chem Biol Drug des"},{"key":"5970_CR133","doi-asserted-by":"publisher","unstructured":"Wagner H, Hill JB (1974) Antiinflammatory sydnones. 1. J Med Chem 17(12):1337\u20131338. https:\/\/doi.org\/10.1021\/jm00258a023","DOI":"10.1021\/jm00258a023"},{"issue":"7","key":"5970_CR134","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3390\/nano7070189","volume":"7","author":"A Watermann","year":"2017","unstructured":"Watermann A, Brieger J (2017) Mesoporous silica nanoparticles as drug delivery vehicles in cancer. Nanomaterials (Basel, Switzerland) 7(7):189. https:\/\/doi.org\/10.3390\/nano7070189","journal-title":"Nanomaterials (Basel, Switzerland)"},{"key":"5970_CR135","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2023.129129","volume":"81","author":"W Xu","year":"2023","unstructured":"Xu W, Yu H, Zhao R, Liang Y (2023) Investigation of mitochondrial targeting ability of sydnones and sydnonimines and mitochondria-targeted delivery of celecoxib. Bioorg Med Chem Lett 81:129129. https:\/\/doi.org\/10.1016\/j.bmcl.2023.129129","journal-title":"Bioorg Med Chem Lett"},{"key":"5970_CR136","doi-asserted-by":"publisher","DOI":"10.1016\/J.MITO.2025.102073","volume":"85","author":"C Yan","year":"2025","unstructured":"Yan C, Li X, Wei P, Zhang X, Wang H, Chen Z, Lin F, Lu G (2025) Targeted mitochondrial metabolism for anti-tumor therapy. Mitochondrion 85:102073. https:\/\/doi.org\/10.1016\/J.MITO.2025.102073","journal-title":"Mitochondrion"},{"issue":"1","key":"5970_CR137","doi-asserted-by":"publisher","first-page":"123","DOI":"10.4067\/S0366-16442000000100016","volume":"45","author":"AL Zanocco","year":"1999","unstructured":"Zanocco AL, Ca\u00f1ete MA, Melendez MX (1999) A kinetic study of the reaction between 2-p- methoxyphenyl-4-phenyl-2-oxazolin-5-one and 2,2,6,6-tetramethyl-1-piperidinyl-n-oxide. Bolet\u00edn de La Sociedad Chilena de Qu\u00edmica 45(1):123\u2013129. https:\/\/doi.org\/10.4067\/S0366-16442000000100016","journal-title":"Bolet\u00edn de La Sociedad Chilena de Qu\u00edmica"},{"key":"5970_CR138","unstructured":"Zaplet\u00e1lek M, H\u00fcbsch T, Kindernayov\u00e1 H (1975) Clinical experience with sydnocarb in neuroses and psychoses. Activitas Nervosa Superior 17(4):235\u2013236. Retrieved September 30, 2026, from Medvik: Clinical experience with sydnocarb in neuroses and psychoses"},{"issue":"10","key":"5970_CR139","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.2174\/0929867329666220620123050","volume":"30","author":"S Zerbib","year":"2022","unstructured":"Zerbib S, Khouili M, Catto M, Bouissane L (2022) Sydnone: synthesis, reactivity and biological activities. Curr Med Chem 30(10):1122\u20131144. https:\/\/doi.org\/10.2174\/0929867329666220620123050","journal-title":"Curr Med Chem"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05970-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05970-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05970-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T21:32:16Z","timestamp":1791667936000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05970-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,10]]},"references-count":139,"alternative-id":["5970"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05970-x","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,10]]},"assertion":[{"value":"21 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors confirm the use of AI tools for language editing and references, using Copilot, Consensus, Perplexity, DeepL and Mendeley. After using these tools, the authors reviewed and edited the content as needed, and take full responsibility for its content.","order":2,"name":"Ethics","label":"Declaration of generative AI use","group":{"name":"EthicsHeading","label":"Declarations"}}]}}